CardioLogical Solutions is a cardiovascular device company that is developing a comprehensive suite of accessory products to address the clinical needs of emerging interventional cardiology procedures such as transcathether aortic valve replacement (TAVR). CardioLogical Solutions represents the merger of two independent companies—Emboline and VasoStitch.
The large-hole access and closure technologies of VasoStitch and the aortic embolic protection technologies of Emboline form the initial core of a suite of accessory devices to address the clinical needs of emerging interventional cardiology procedures. Added to these is a novel approach to preventing contrast nephropathy during cardiovascular procedures.
"The broad portfolio of CardioLogical Solutions represents the most comprehensive range of accessory products for the TAVR community. Our technologies address the three biggest clinical needs in TAVR, with superior technologies and a broad intellectual property portfolio."
— David W. J. Smith, CEO of CardioLogical Solutions